Genomic Valley Biotech Ltd Financials

Genomic Valley Biotech Ltd Financial Statement

Genomic Valley Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	0.21	0.16	TBA
Operating Expense	0.06	0.03	0.04
Net Profit	0.15	0.13	-0.04
Net Profit Margin	71.43	81.25	TBA
Earning Per Share	0.48	0.42	-0.15
EBIDTA	0.15	0.13	-0.04
Effective Tax Rate	TBA	TBA	TBA

Particulars	Sep 2024
Revenue	0.21
Operating Expense	0.06
Net Profit	0.15
Net Profit Margin	71.43
Earning Per Share	0.48
EBIDTA	0.15
Effective Tax Rate	TBA

Genomic Valley Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	0.17	2.72	0.07
Operating Expenses Annual	0.15	1.84	0.45
Operating Profit Annual	0.02	0.66	0.13
Interest Annual	TBA	TBA	0.04
Depreciation	0.00	0.01	0.08
Net Profit Annual	0.02	0.65	-0.01
Tax Annual	-0.00	0.00	0.01

Particulars	Mar 2024
Total Revenue Annual	0.17
Operating Expenses Annual	0.15
Operating Profit Annual	0.02
Interest Annual	TBA
Depreciation	0.00
Net Profit Annual	0.02
Tax Annual	-0.00

Genomic Valley Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.04	TBA	0.01
Cash Flow from Operations	-0.02	-0.78	-2.13
Cash Flow from Investing	-0.02	1.52	3.67
Cash Flow from Financing	TBA	-0.70	-1.55
Cash Flow at the End	0.01	0.04	TBA

Particulars	Mar 2024
Cash Flow at the Beginning	0.04
Cash Flow from Operations	-0.02
Cash Flow from Investing	-0.02
Cash Flow from Financing	TBA
Cash Flow at the End	0.01

Genomic Valley Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	11.76	33.82	-428.57
PBIT Margin (%)	11.76	33.46	-542.86
PBT Margin (%)	11.76	33.46	13,028.57
Net PROFIT Margin (%)	11.76	23.90	-14.29
Return On Networth / Equity (%)	0.57	28.48	TBA
Return On Networth /Employed (%)	0.57	25.67	TBA
Return On Assets (%)	0.59	18.40	-0.14
Total Debt / Equity (X)	TBA	TBA	0.21
Asset Turnover Ratio (%)	0.05	0.77	0.01

Particulars	Mar 2024
PBDIT Margin (%)	11.76
PBIT Margin (%)	11.76
PBT Margin (%)	11.76
Net PROFIT Margin (%)	11.76
Return On Networth / Equity (%)	0.57
Return On Networth /Employed (%)	0.57
Return On Assets (%)	0.59
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	0.05

Genomic Valley Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.00	0.00	1.75
Total Current Assets Annual	2.91	2.58	1.14
Non Current Assets Annual	1.42	1.84	2.66
Total Shareholders Funds Annual	3.54	3.53	2.88
Total Assets Annual	4.33	4.42	3.80

Particulars	Mar 2024
Fixed Assets Annual	0.00
Total Current Assets Annual	2.91
Non Current Assets Annual	1.42
Total Shareholders Funds Annual	3.54
Total Assets Annual	4.33

Genomic Valley Biotech Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Genomic Valley Biotech Ltd has a market capitalization of 10.60 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Genomic Valley Biotech Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , Genomic Valley Biotech Ltd recorded a total revenue of approximately 0.17 Cr marking a significant milestone in the company's financial performance.

Genomic Valley Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.4% annually, respectively..

Genomic Valley Biotech Ltd's current PE ratio is 530.00.

Genomic Valley Biotech Ltd's ROCE averaged 5.3% from the FY ending March 2022 to 2024, with a median of 0.4%. It peaked at 25.9% in March 2023, reflecting strong capital efficiency over the period..

Genomic Valley Biotech Ltd's latest EBIT is Rs. 0.02 Cr, surpassing the average EBIT of Rs. 0.24 Cr over the 5 years..